Life Sciences

life

Advanced Schools present the cutting edge of research to young academics, who learn about the most recent developments in their fields from world-class scholars.

The annual Advanced School in Life Sciences introduces students and postdoctoral fellows to key discoveries in the life sciences, as well as providing personal perspectives from leaders in the field. Participants are also exposed to technical and conceptual challenges.

Professor Roger Kornberg, Nobel laureate, acts as the School’s General Director.

General Director

roger_kornberg

Roger Kornberg

General Director - current
Life Sciences
Stanford University

structural biology

Roger D. Kornberg is an American biochemist and professor of structural biology at Stanford University School of Medicine. Kornberg was awarded the Nobel Prize in Chemistry in 2006 for his studies of the process by which genetic information from DNA is copied to RNA, "the molecular basis of eukaryotic transcription.”

> See All directors

Upcoming School

Life Sciences - UPCOMING SCHOOL

2022 life sciences school

The 28th Advanced School in Life Sciences: Novel roles for RNA in Biology and Therapy

Read More

 

23-27 October 2022

 

GENERAL DIRECTOR: 

Roger Kornberg (Stanford University)

 

ORGANIZER:

Ruth Sperling, The Hebrew University of Jerusalem

 

Research during recent decades has identified RNA molecules as key players in biology and medicine. Novel types of large and small RNAs, and novel roles for RNA molecules, not only as informational molecules, but also as enzymes and as regulators of gene expression, have emerged. RNA processing and alternative splicing, major contributors to proteome versatility, play crucial roles in cell identity and development.  RNA molecules serve as catalysts and as regulators of chromatin structure, gene expression at different levels, and protein function in diverse pathways. The involvement of RNA molecules in disease-related processes has led to RNA-mediated therapies. For example, manipulation of alternative splicing and gene expression by antisense RNAs enabled breakthroughs in the therapies of rare disease, and mRNA-based vaccines have played a crucial role in the fight against the COVID-19 pandemic. Many challenges lie ahead in deciphering the structure and function of RNA molecules and in the development of additional RNA-based therapies. The RNA School will bring together many of the scientists responsible for the important discoveries, and will support stimulating and fruitful discussions of the major topics.    

As part of the school, we will hold the Israeli RNA Society meeting in memory of Prof. Yossi Sperling on 26 October.

 

SPEAKERS:

 

Gil Ast, Tel Aviv University
Maria Carmo-Fonseca, University of Lisbon
Chonghui Cheng, Baylor College of Medicine
Matthias W. Hentze, European Molecular Biology Laboratory
Eran Hornstein, Weizmann Institute of Science
Batsheva Kerem, The Hebrew University of Jerusalem
Adrian R. Krainer, Cold Spring Harbor Laboratories
Erez Levanon, Bar-Ilan University
Reinhard Lührmann, Max-Planck-Institute for Biophysical Chemistry
Yael Mandel-Gutfreund, Technion
Hanah Margalit, The Hebrew University of Jerusalem
Lynne E. Maquat, University of Rochester Medical Center
Shulamit Michaeli, Bar-Ilan University
Gideon Rechavi, Sheba Medical Center & Tel Aviv University
Michal Shapira, Ben-Gurion University of the Negev
Yaron Shav-Tal, Bar-Ilan University
Noam Stern-Ginossar, Weizmann Institute of Science
Yehuda Tzfati, The Hebrew University of Jerusalem
Igor Ulitsky, Weizmann Institute of Science
Ada Yonath, Weizmann Institute of Science

 

Application Form

Israeli RNA Society Meeting

 

Read Less
> See All schools in Life Sciences